JPH0959211A - Novel optically active dicarboxylic acid derivative and method for producing the same - Google Patents
Novel optically active dicarboxylic acid derivative and method for producing the sameInfo
- Publication number
- JPH0959211A JPH0959211A JP21793895A JP21793895A JPH0959211A JP H0959211 A JPH0959211 A JP H0959211A JP 21793895 A JP21793895 A JP 21793895A JP 21793895 A JP21793895 A JP 21793895A JP H0959211 A JPH0959211 A JP H0959211A
- Authority
- JP
- Japan
- Prior art keywords
- optically active
- dicarboxylic acid
- acid derivative
- microorganism
- novel optically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 title claims description 11
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 244000005700 microbiome Species 0.000 claims abstract description 18
- 108090000790 Enzymes Proteins 0.000 claims abstract description 5
- 102000004190 Enzymes Human genes 0.000 claims abstract description 5
- 241000589516 Pseudomonas Species 0.000 claims abstract description 3
- 241000588722 Escherichia Species 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract 2
- 230000000813 microbial effect Effects 0.000 claims description 6
- -1 dicarboxylic acid diester Chemical class 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 abstract description 9
- 150000001875 compounds Chemical class 0.000 abstract description 6
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 abstract description 5
- 150000005690 diesters Chemical class 0.000 abstract description 4
- 229910052799 carbon Inorganic materials 0.000 abstract description 2
- 230000003301 hydrolyzing effect Effects 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000002609 medium Substances 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000012429 reaction media Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108090000371 Esterases Proteins 0.000 description 2
- 241000589776 Pseudomonas putida Species 0.000 description 2
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- LHJHRVVZHAHRCZ-UHFFFAOYSA-N dimethyl 2,5-dimethylhexanedioate Chemical compound COC(=O)C(C)CCC(C)C(=O)OC LHJHRVVZHAHRCZ-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 102220201851 rs143406017 Human genes 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は新規光学活性カルボ
ン酸誘導体及びそれを製造する方法に関する。TECHNICAL FIELD The present invention relates to a novel optically active carboxylic acid derivative and a method for producing the same.
【0002】[0002]
一般式(I): General formula (I):
【0003】[0003]
【化4】 Embedded image
【0004】で表される新規光学活性ジカルボン酸誘導
体及びそれらの製造方法に関しては従来知られていな
い。The novel optically active dicarboxylic acid derivative represented by and the method for producing them have not been known so far.
【0005】[0005]
【発明が解決しようとする課題】本発明の目的は、各種
光学活性化合物の合成中間体としての用途が期待される
前記一般式(I)で表される新規光学活性不飽和ジカル
ボン酸誘導体及びそれらの製造方法を提供することにあ
る。The object of the present invention is to provide novel optically active unsaturated dicarboxylic acid derivatives represented by the above general formula (I), which are expected to be used as synthetic intermediates for various optically active compounds, and their derivatives. It is to provide a manufacturing method of.
【0006】[0006]
【課題を解決するための手段】即ち、本発明は、下記の
一般式(I):That is, the present invention provides the following general formula (I):
【0007】[0007]
【化5】 Embedded image
【0008】で表される新規光学活性ジカルボン酸誘導
体にある。A novel optically active dicarboxylic acid derivative represented by
【0009】更に、本発明は、下記の一般式(II):Further, the present invention provides the following general formula (II):
【0010】[0010]
【化6】 [Chemical 6]
【0011】で表されるラセミ体ジカルボン酸ジエステ
ルに、エステル結合を不斉加水分解する能力を有する微
生物の培養物、菌体又は菌体処理物を作用させて前記一
般式(I)で表される新規光学活性ジカルボン酸誘導体
を製造する方法にある。The racemic dicarboxylic acid diester represented by the formula (I) is represented by the action of a culture of a microorganism having the ability to asymmetrically hydrolyze an ester bond, a microbial cell or a treated product of the microbial cell. Another method is to produce a novel optically active dicarboxylic acid derivative.
【0012】本発明において用いる前記一般式(II)で
表されるラセミ体ジカルボン酸ジエステルは、分子内に
2つの不斉点を持ち、(2S,5S)、(2S,5
R)、(2R,5S)、(2R,5R)の4種類のジア
ステレオマーが存在する。このジアステレオマー混合物
にα−メチル側鎖の絶対配置が(R)体に相当するエス
テル部位を認識し、不斉加水分解する能力を有する微生
物の培養物、菌体又は菌体処理物を作用させ、(2S,
5R)、(2R,5S)、(2R,5R)体を不斉加水
分解してカルボン酸とし、未反応の(2S,5S)体ジ
エステルを光学的に純粋に単離することが可能であるこ
とを見い出し、本発明を完成したものである。The racemic dicarboxylic acid diester represented by the general formula (II) used in the present invention has two asymmetric points in the molecule, and has (2S, 5S), (2S, 5)
There are four types of diastereomers, R), (2R, 5S) and (2R, 5R). This diastereomer mixture acts on a culture, a microbial cell or a treated product of a microorganism having an ability to recognize an ester site whose absolute configuration of α-methyl side chain corresponds to the (R) -form and asymmetrically hydrolyze. Let (2S,
5R), (2R, 5S) and (2R, 5R) isomers are asymmetrically hydrolyzed to carboxylic acids, and the unreacted (2S, 5S) isomer diester can be isolated optically pure. The present invention has been discovered and the present invention has been completed.
【0013】前記式中、Rは酵素反応の基質となるよう
なものであればどのようなものでも良いが、例えばメチ
ル基、エチル基、プロピル基、イソプロピル基、ブチル
基、イソブチル基等が例示できる。In the above formula, R may be any as long as it serves as a substrate for an enzymatic reaction, and examples thereof include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group and an isobutyl group. it can.
【0014】本発明で用いる微生物は、前記一般式(I
I)で表されるラセミ体ジカルボン酸ジエステルのエス
テル結合を不斉加水分解する能力を有するものであれば
どのようなものも使用可能である。代表的なものとして
は、シュードモナス(Pseudomonas)属又はエセリキア(Es
cherichia)属に属する微生物が挙げられる。具体的には
シュードモナス・プチダ(Pseudomonas putida)MR-2068
(FERM BP-3846)、エセリキア・コリ(Escherichia coli)
MR-2103(FERM BP-3835)が挙げられる。エセリキア・コ
リ(Escherichia coli)MR-2103(FERM BP-3835)は、シュ
ードモナス・プチダ(Pseudomonas putida)MR-2068(FERM
BP-3846)由来のエステラーゼ遺伝子で形質転換された
株である。The microorganism used in the present invention has the general formula (I
Any compound having the ability to asymmetrically hydrolyze the ester bond of the racemic dicarboxylic acid diester represented by I) can be used. Typical examples include the genus Pseudomonas or Esericia.
Examples include microorganisms belonging to the genus cherichia. Specifically, Pseudomonas putida MR-2068
(FERM BP-3846), Escherichia coli
MR-2103 (FERM BP-3835) is mentioned. Escherichia coli MR-2103 (FERM BP-3835) is Pseudomonas putida MR-2068 (FERM
It is a strain transformed with the esterase gene derived from BP-3846).
【0015】本発明で用いる微生物の培養は、液体培地
でも固体培地でも行うことができる。培地としては、微
生物が通常資化しうる炭素源、窒素源、ビタミン、ミネ
ラル等の成分を適宜配合したものが用いられる。微生物
の加水分解能を向上させるため、培地にエステルを少量
添加することも可能である。培養は微生物が生育可能で
ある温度、pHで行われるが、使用する菌株の最適培養
条件で行うことが好ましい。微生物の生育を促進させる
ため、通気攪拌を行ってもよい。The culture of the microorganism used in the present invention can be carried out in a liquid medium or a solid medium. As the medium, a medium appropriately mixed with components such as a carbon source, a nitrogen source, vitamins, and minerals that can normally be used by microorganisms is used. It is also possible to add a small amount of ester to the medium in order to improve the ability of the microorganism to hydrolyze. The culture is carried out at a temperature and pH at which the microorganism can grow, but it is preferably carried out under the optimum culture conditions of the strain to be used. Aeration and agitation may be performed to promote the growth of microorganisms.
【0016】加水分解反応を行うに際しては、培養の開
始時又は途中で培地にエステルを添加してもよく、予め
微生物を培養した後、培養液にエステルを添加してもよ
い。また増殖した微生物の菌体を遠心分離等により採取
し、これをエステルを含む反応媒体に加えてもよい。菌
体としては、アセトン、トルエン等で処理した菌体を用
いてもよい。When carrying out the hydrolysis reaction, the ester may be added to the medium at the start or during the culture, or the ester may be added to the culture solution after culturing the microorganism in advance. Alternatively, the cells of the grown microorganism may be collected by centrifugation or the like and added to the reaction medium containing the ester. As the bacterial cells, bacterial cells treated with acetone, toluene or the like may be used.
【0017】また、菌体の代わりに、培養液等の培養
物、菌体破砕物、菌体抽出物、粗酵素、精製酵素等の菌
体処理物を用いてもよく、更に、酵素又は微生物を適当
な担体に固定化し、反応を行った後に回収再利用するこ
とも可能である。ここで、酵素としては微生物由来の各
種リパーゼ、プロテアーゼ及びエステラーゼが使用可能
である。Further, instead of the cells, a culture such as a culture solution, a disrupted cell, a cell extract, a crude enzyme, a purified enzyme or the like treated cell may be used. It is also possible to immobilize on a suitable carrier, carry out the reaction, and then collect and reuse. Here, as the enzyme, various microbial-derived lipases, proteases and esterases can be used.
【0018】反応媒体としては、例えばイオン交換水、
緩衝液が用いられる。反応媒体又は培養液中のエステル
濃度としては、0.1〜70重量%が好ましいが、更に
好ましくは5〜40%である。メタノール、アセトン、
界面活性剤等を反応系に添加することも可能である。反
応液のpHは、2〜11、好ましくは5〜8の範囲であ
る。反応が進行するに従い生成したカルボン酸により反
応液のpHが低下してくるが、この場合は適当な中和剤
で最適pHに維持することが好ましい。反応温度は5〜
70℃が好ましく、10〜60℃が更に好ましい。As the reaction medium, for example, ion-exchanged water,
A buffer is used. The ester concentration in the reaction medium or culture medium is preferably 0.1 to 70% by weight, more preferably 5 to 40%. Methanol, acetone,
It is also possible to add a surfactant or the like to the reaction system. The pH of the reaction solution is in the range of 2 to 11, preferably 5 to 8. As the reaction progresses, the pH of the reaction solution decreases due to the carboxylic acid formed. In this case, it is preferable to maintain the pH at an optimum level with a suitable neutralizing agent. The reaction temperature is 5
70 degreeC is preferable and 10-60 degreeC is more preferable.
【0019】反応終了液からの生産物の分離精製は、酢
酸エチル、クロロホルム、ジエチルエーテル等の有機溶
媒による抽出を行い、次いで蒸留あるいはカラムクロマ
トグラフィー等の通常の精製法を適用することにより、
光学活性ジカルボン酸誘導体を取得することができる。For separation and purification of the product from the reaction-terminated liquid, extraction with an organic solvent such as ethyl acetate, chloroform, diethyl ether, etc. is carried out, and then a conventional purification method such as distillation or column chromatography is applied.
An optically active dicarboxylic acid derivative can be obtained.
【0020】[0020]
【実施例】以下、本発明を実施例により更に詳しく説明
するが、これらに限定されるものではない。EXAMPLES The present invention will be described in more detail with reference to examples below, but the invention is not limited thereto.
【0021】[実施例1](2S,5S)−ジメチルヘ
キサン二酸ジメチルエステルの製造 エセリキア・コリ(Escherichia coli)MR-2103(FERM BP-
3835)を50μg/mlのアンピシリンを含むLB培地
(1%ポリペプトン、0.5%酵母エキス、0.5%N
aCl)500mlに植菌し、37℃、20時間振盪培
養した。培養終了後、培養液を遠心分離し、得られた菌
体の全量をイオン交換水で洗浄した後、50mM燐酸緩
衝液(pH7.0)500mlに懸濁した。この菌体懸
濁液に、ラセミ体2,5−ジメチルヘキサン二酸ジメチ
ルエステル50gを加え、30℃で20時間反応させ
た。この間、反応液のpHは、1N NaOH水溶液を
用いて7.0に調整した。反応終了後、遠心分離により
菌体を除き、未反応の2,5−ジメチルヘキサン二酸ジ
メチルエステルを酢酸エチルで抽出した。有機層に無水
硫酸ナトリウムを加えて脱水し、溶媒を蒸発除去し、更
に蒸留精製し、9.6gのジエステル画分を得た。Example 1 Production of (2S, 5S) -dimethylhexanedioic acid dimethyl ester Escherichia coli MR-2103 (FERM BP-
3835) in LB medium containing 50 μg / ml of ampicillin (1% polypeptone, 0.5% yeast extract, 0.5% N).
(aCl) was inoculated into 500 ml and cultured with shaking at 37 ° C. for 20 hours. After the completion of the culture, the culture solution was centrifuged, the whole amount of the obtained bacterial cells was washed with ion-exchanged water, and then suspended in 500 ml of 50 mM phosphate buffer (pH 7.0). To this cell suspension, 50 g of racemic 2,5-dimethylhexanedioic acid dimethyl ester was added and reacted at 30 ° C. for 20 hours. During this period, the pH of the reaction solution was adjusted to 7.0 using a 1N NaOH aqueous solution. After completion of the reaction, cells were removed by centrifugation and unreacted 2,5-dimethylhexanedioic acid dimethyl ester was extracted with ethyl acetate. Anhydrous sodium sulfate was added to the organic layer for dehydration, the solvent was removed by evaporation, and the residue was further purified by distillation to obtain a diester fraction of 9.6 g.
【0022】得られたジエステル画分の物性データを以
下に示す。Physical property data of the obtained diester fraction are shown below.
【0023】 (2S,5S)−ジメチルヘキサン二酸ジメチルエステル <1H−NMRスペクトル> CDCl3 内部標準TMS(第1図) δH 1.14〜1.16 (6H,d,−CH3) δH 1.43〜1.45 (2H,m,−CH2−) δH 1.63〜1.66 (2H,m,−CH2−) δH 2.43〜2.45 (2H,q,−CH−) δH 3.68 (6H,s,−COOCH3) <13C−NMRスペクトル> CDCl3 内部標準TMS(第2図) δc 16.98 (−CH3) δc 31.18 (−CH−) δc 39.31 (−CH2−) δc 51.77 (−COOCH3) δc 176.83 (C=O) <比旋光度> [α]25 D =+28.8゜(neat)(2S, 5S) -Dimethylhexanedioic acid dimethyl ester < 1 H-NMR spectrum> CDCl 3 internal standard TMS (FIG. 1) δ H 1.14 to 1.16 (6H, d, -CH 3 ). δ H 1.43 to 1.45 (2H, m, -CH 2- ) δ H 1.63 to 1.66 (2H, m, -CH 2- ) δ H 2.43 to 2.45 (2H, q, -CH-) δ H 3.68 ( 6H, s, -COOCH 3) <13 C-NMR spectrum> CDCl 3 internal standard TMS (Figure 2) δ c 16.98 (-CH 3) δ c 31 .18 (-CH-) δ c 39.31 ( -CH 2 -) δ c 51.77 (-COOCH 3) δ c 176.83 (C = O) < specific rotation> [α] 25 D = + 28 .8 ° (neat)
【0024】[0024]
【発明の効果】本発明によれば各種光学活性化合物の合
成中間体としての用途が期待される前記一般式(I)で
表される新規光学活性ジカルボン酸誘導体が得られる。INDUSTRIAL APPLICABILITY According to the present invention, a novel optically active dicarboxylic acid derivative represented by the above general formula (I), which is expected to be used as a synthetic intermediate for various optically active compounds, can be obtained.
【図1】実施例1で得られた(2S,5S)−ジメチル
ヘキサン二酸ジメチルエステルの1H−NMRスペクト
ル図である。FIG. 1 is a 1 H-NMR spectrum diagram of (2S, 5S) -dimethylhexanedioic acid dimethyl ester obtained in Example 1.
【図2】実施例1で得られた(2S,5S)−ジメチル
ヘキサン二酸ジメチルエステルの13C−NMRスペクト
ル図である。FIG. 2 is a 13 C-NMR spectrum diagram of (2S, 5S) -dimethylhexanedioic acid dimethyl ester obtained in Example 1.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C12R 1:19) C07M 7:00 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Internal reference number FI technical display location C12R 1:19) C07M 7:00
Claims (4)
ル結合を不斉加水分解する能力を有する微生物の培養
物、菌体又は菌体処理物を作用させて下記の一般式
(I): 【化3】 で表される新規光学活性ジカルボン酸誘導体を製造する
方法。2. The following general formula (II): The racemic dicarboxylic acid diester represented by the formula (I) below is reacted with a culture of a microorganism having the ability to asymmetrically hydrolyze an ester bond, a microbial cell or a treated product of the microbial cell. A method for producing a novel optically active dicarboxylic acid derivative represented by:
する微生物がシュードモナス(Pseudomonas)属又はエセ
リキア(Escherichia)属に属する微生物であることを特
徴とする請求項2の新規光学活性ジカルボン酸誘導体を
製造する方法。3. The novel optically active dicarboxylic acid derivative according to claim 2, wherein the microorganism having the ability to asymmetrically hydrolyze an ester bond is a microorganism belonging to the genus Pseudomonas or the genus Escherichia. Method of manufacturing.
する微生物が、エステル結合を不斉加水分解する酵素を
コードする遺伝子により形質転換された遺伝子操作微生
物であることを特徴とする請求項2の新規光学活性ジカ
ルボン酸誘導体を製造する方法。4. The microorganism having the ability to asymmetrically hydrolyze an ester bond is a genetically engineered microorganism transformed with a gene encoding an enzyme that asymmetrically hydrolyzes an ester bond. A method for producing a novel optically active dicarboxylic acid derivative.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21793895A JPH0959211A (en) | 1995-08-25 | 1995-08-25 | Novel optically active dicarboxylic acid derivative and method for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21793895A JPH0959211A (en) | 1995-08-25 | 1995-08-25 | Novel optically active dicarboxylic acid derivative and method for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0959211A true JPH0959211A (en) | 1997-03-04 |
Family
ID=16712067
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21793895A Pending JPH0959211A (en) | 1995-08-25 | 1995-08-25 | Novel optically active dicarboxylic acid derivative and method for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0959211A (en) |
-
1995
- 1995-08-25 JP JP21793895A patent/JPH0959211A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS63284184A (en) | Optically active compound and production thereof | |
| US5773240A (en) | Optically active α-substituted carboxylic acid derivatives and method for producing the same | |
| JP3732535B2 (en) | Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester | |
| EP0237080B1 (en) | Process for the preparation of l(-)-carnitine chloride starting from 3,4-epoxybutyric esters | |
| JPH0959211A (en) | Novel optically active dicarboxylic acid derivative and method for producing the same | |
| JP2645342B2 (en) | Preparation of optically active substituted 4-hydroxy-2-cyclopentenone | |
| JPH0959217A (en) | Novel optically active halogen-containing carboxylic acid derivative and method for producing the same | |
| JP3970898B2 (en) | Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester | |
| JP3072150B2 (en) | Method for producing optically active [3] (1,1 ') ferrocenophanes | |
| JPH10210997A (en) | Production of optically active 3-quinacridinol | |
| JPH0965891A (en) | Method for producing optically active α-methylalkanoic acid derivative | |
| JPH08259500A (en) | Novel optically active unsaturated carboxylic acid derivative and method for producing the same | |
| JP2639651B2 (en) | Process for producing optically active carboxylic acid and its enantiomer ester | |
| JPH1014590A (en) | Production of optically active 2-substituted-3-phenylpropionic acid and its ester | |
| JP2000023693A (en) | Method for producing optically active 2-acetylthio-3-phenylpropionic acid | |
| JP3715662B2 (en) | Process for producing optically active β-hydroxycarboxylic acid and its enantiomer ester | |
| JP4565672B2 (en) | Optically active β-cyanoisobutyric acid and process for producing the same | |
| JPH0573396B2 (en) | ||
| JP2645341B2 (en) | Method for producing optically active substituted 4-hydroxy-2-cyclopentenone | |
| JP3024298B2 (en) | Cyclopentene esters and their use | |
| JP4746019B2 (en) | Optically active β-cyanoisobutyric acid and process for producing the same | |
| JP2615768B2 (en) | Optically active carboxylic acid derivative and method for producing the same | |
| JPH0662892A (en) | Production of 2-indoline-2-carboxylic acid by optical resolution | |
| JP4834208B2 (en) | Method for producing (2S, 3R) -2,3-epoxybutyric acid ester | |
| JPH1160539A (en) | Optically active tans-3,3-dialkoxy-1,2-cyclobutanedicarboxlic acid ester and its production |